IGF1 and gastric cancer: The pronounced reduction in phosphorylation of ERK1 and ERK2 after knockdown of the type I IGF receptor in KRAS-mutant SNU-1 gastric cancer cells is consistent with primary activation of their Ras/Raf/MAP-kinase pathway being dependent upon stimulus through the IGF signal transduction system.